Video Upload Options

References

1. Audenet F, Attalla K, Sfakianos JP. The evolution of bladder cancer genomics: What have we learned and how can we use it? Urol Oncol. 2018 Jul;36(7):313-320.doi: 10.1016/j.urolonc.2018.02.017.
2. Chereda B, Melo JV. Natural course and biology of CML. Ann Hematol. 2015Apr;94 Suppl 2:S107-21. doi: 10.1007/s00277-015-2325-z.
3. Coco S, Valdora F, Bonassi S, Scaruffi P, Stigliani S, Oberthuer A, BertholdF, Andolfo I, Servidei T, Riccardi R, Basso E, Iolascon A, Tonini GP. Chromosome 9q and 16q loss identified by genome-wide pooled-analysis are associated withtumor aggressiveness in patients with classic medulloblastoma. OMICS. 2011May;15(5):273-80. doi: 10.1089/omi.2010.0103.
4. De Braekeleer E, Douet-Guilbert N, Rowe D, Bown N, Morel F, Berthou C, FérecC, De Braekeleer M. ABL1 fusion genes in hematological malignancies: a review.Eur J Haematol. 2011 May;86(5):361-71. doi: 10.1111/j.1600-0609.2011.01586.x.
5. Gilbert F, Kauff N. Disease genes and chromosomes: disease maps of the humangenome. Chromosome 9. Genet Test. 2001 Summer;5(2):157-74.
6. Hoischen A, Ehrler M, Fassunke J, Simon M, Baudis M, Landwehr C, Radlwimmer B,Lichter P, Schramm J, Becker AJ, Weber RG. Comprehensive characterization ofgenomic aberrations in gangliogliomas by CGH, array-based CGH and interphaseFISH. Brain Pathol. 2008 Jul;18(3):326-37. doi: 10.1111/j.1750-3639.2008.00122.x.
7. Humphray SJ, Oliver K, Hunt AR, Plumb RW, Loveland JE, Howe KL, Andrews TD,Searle S, Hunt SE, Scott CE, Jones MC, Ainscough R, Almeida JP, Ambrose KD,Ashwell RI, Babbage AK, Babbage S, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beasley H, Beasley O, Bird CP, Bray-Allen S, Brown AJ, Brown JY, Burford D, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Chen Y,Clarke G, Clark SY, Clee CM, Clegg S, Collier RE, Corby N, Crosier M, CummingsAT, Davies J, Dhami P, Dunn M, Dutta I, Dyer LW, Earthrowl ME, Faulkner L,Fleming CJ, Frankish A, Frankland JA, French L, Fricker DG, Garner P, Garnett J, Ghori J, Gilbert JG, Glison C, Grafham DV, Gribble S, Griffiths C,Griffiths-Jones S, Grocock R, Guy J, Hall RE, Hammond S, Harley JL, Harrison ES, Hart EA, Heath PD, Henderson CD, Hopkins BL, Howard PJ, Howden PJ, Huckle E,Johnson C, Johnson D, Joy AA, Kay M, Keenan S, Kershaw JK, Kimberley AM, King A, Knights A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, LloydC, Lloyd DM, Lovell J, Martin S, Mashreghi-Mohammadi M, Matthews L, McLaren S,McLay KE, McMurray A, Milne S, Nickerson T, Nisbett J, Nordsiek G, Pearce AV,Peck AI, Porter KM, Pandian R, Pelan S, Phillimore B, Povey S, Ramsey Y, Rand V, Scharfe M, Sehra HK, Shownkeen R, Sims SK, Skuce CD, Smith M, Steward CA,Swarbreck D, Sycamore N, Tester J, Thorpe A, Tracey A, Tromans A, Thomas DW, WallM, Wallis JM, West AP, Whitehead SL, Willey DL, Williams SA, Wilming L, Wray PW, Young L, Ashurst JL, Coulson A, Blöcker H, Durbin R, Sulston JE, Hubbard T,Jackson MJ, Bentley DR, Beck S, Rogers J, Dunham I. DNA sequence and analysis of human chromosome 9. Nature. 2004 May 27;429(6990):369-74.
8. Mhawech-Fauceglia P, Cheney RT, Schwaller J. Genetic alterations in urothelialbladder carcinoma: an updated review. Cancer. 2006 Mar 15;106(6):1205-16. Review.
9. Muller EA, Aradhya S, Atkin JF, Carmany EP, Elliott AM, Chudley AE, Clark RD, Everman DB, Garner S, Hall BD, Herman GE, Kivuva E, Ramanathan S, Stevenson DA,Stockton DW, Hudgins L. Microdeletion 9q22.3 syndrome includes metopiccraniosynostosis, hydrocephalus, macrosomia, and developmental delay. Am J MedGenet A. 2012 Feb;158A(2):391-9. doi: 10.1002/ajmg.a.34216.
10. Redon R, Baujat G, Sanlaville D, Le Merrer M, Vekemans M, Munnich A, CarterNP, Cormier-Daire V, Colleaux L. Interstitial 9q22.3 microdeletion: clinical and molecular characterisation of a newly recognised overgrowth syndrome. Eur J HumGenet. 2006 Jun;14(6):759-67.
11. Stewart DR, Kleefstra T. The chromosome 9q subtelomere deletion syndrome. Am JMed Genet C Semin Med Genet. 2007 Nov 15;145C(4):383-92. Review.
12. Willemsen MH, Beunders G, Callaghan M, de Leeuw N, Nillesen WM, Yntema HG, vanHagen JM, Nieuwint AW, Morrison N, Keijzers-Vloet ST, Hoischen A, Brunner HG,Tolmie J, Kleefstra T. Familial Kleefstra syndrome due to maternal somaticmosaicism for interstitial 9q34.3 microdeletions. Clin Genet. 2011Jul;80(1):31-8. doi: 10.1111/j.1399-0004.2010.01607.x.
13. Wolff EM, Liang G, Jones PA. Mechanisms of Disease: genetic and epigeneticalterations that drive bladder cancer. Nat Clin Pract Urol. 2005Oct;2(10):502-10. Review.
14. Yatsenko SA, Brundage EK, Roney EK, Cheung SW, Chinault AC, Lupski JR.Molecular mechanisms for subtelomeric rearrangements associated with the 9q34.3microdeletion syndrome. Hum Mol Genet. 2009 Jun 1;18(11):1924-36. doi:10.1093/hmg/ddp114.